Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Mountain Group Partners (MGP) is a venture capital firm based in Nashville, Tennessee, founded in 2002. With over 20 years of experience, MGP has established itself as a key player in the venture capital landscape, focusing on sectors that are often overlooked by traditional investors. The firm emphasizes a long-term investment strategy, viewing itself as a builder of businesses rather than just a provider of capital.
As of now, MGP manages approximately $300 million in assets under management (AUM) and has invested in over 75 companies throughout its history. The firm operates with a team that boasts over 100 years of combined operational experience, allowing them to provide significant support to their portfolio companies. MGP has closed three funds to date, with the latest, MGP Venture Fund III, raising $128 million in June 2022.
Mountain Group Partners is committed to investing in early-stage companies primarily in North America, with a focus on life sciences and disruptive technologies. Their portfolio reflects a diverse range of innovative companies, particularly in healthcare and technology.
MGP primarily invests in early-stage companies across several sectors, including healthcare, biotech, fintech, energy, and climate. The firm has a particular emphasis on life sciences, focusing on diagnostics and animal health, which they believe are critical for the advancement of personalized medicine. Their investment strategy also encompasses disruptive technologies that demonstrate practical applications in healthcare, business services, and renewable energy.
The firm targets seed, Series A, Series B, and growth equity stages, with check sizes typically ranging from $5 million to $15 million for early rounds. MGP seeks to partner with companies that are addressing unique and underserved areas within these sectors, providing not only capital but also operational expertise and strategic guidance to help them scale effectively.
Mountain Group Partners has built a diverse portfolio of over 75 companies, with notable investments including:
This portfolio reflects MGP's commitment to investing in transformative technologies that have the potential to make a significant impact in their respective fields.
Byron Smith - Managing Director. Byron has extensive experience in venture capital and operational management, having worked with various startups across multiple sectors.
Joe Cook, III - Managing Director. Joe has a strong background in healthcare investments and has led numerous successful funding rounds in the life sciences sector.
Rob Readnour - Managing Director. Rob specializes in animal health and has a proven track record of supporting companies in this niche.
Joe Cook, Jr. - Managing Director. Joe brings a wealth of experience in business development and strategic planning to the firm.
Jack Slaughter - Principal. Jack focuses on sourcing new investment opportunities and supporting portfolio companies in their growth strategies.
To pitch Mountain Group Partners, founders should visit their website at mtngp.com. It is essential to include a comprehensive deck that outlines the business model, market analysis, and team qualifications. MGP prefers to receive pitches through their online portal, ensuring that all submissions are organized and reviewed efficiently.
Response times can vary, but founders should expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory. MGP values direct communication and clarity in pitches, which can help facilitate a quicker review process.
In January 2024, Mountain Group Partners co-led an $8.3 million Series A round for Circular Genomics, focusing on RNA-based genomic assays. In July 2024, they led a $14 million convertible note for Mindera Health, which develops dermal biomarker patches for treatment response prediction.
In April 2024, MGP participated in a $40 million Series A round for PinkDx, followed by a $5 million Series A extension in January 2025. Additionally, in May 2022, they co-led a $35 million Series C round for TARGAN, marking a significant investment in poultry vaccine delivery systems.
What are Mountain Group Partners' investment criteria?
MGP focuses on early-stage companies in the life sciences and disruptive technology sectors, particularly those that are often underserved by traditional venture capital. They look for businesses that demonstrate real utility and traction in their respective markets.
How can I pitch to Mountain Group Partners?
Founders can submit their pitches through the Mountain Group Partners website at mtngp.com. It is recommended to include a clear business model, market analysis, and details on the team.
What makes Mountain Group Partners different from other VC firms?
MGP emphasizes a hands-on approach, providing operational expertise and strategic guidance to its portfolio companies. They view themselves as business builders, not just financial investors.
What is the geographic focus of Mountain Group Partners?
The firm primarily invests in companies based in North America, allowing them to leverage their local knowledge and networks.
What is the typical check size for investments?
MGP typically leads or co-leads seed and Series A rounds with investments ranging from $5 million to $15 million. They also participate in follow-on rounds as needed.
What kind of support do portfolio companies receive?
Mountain Group Partners provides strategic guidance, operational support, and access to a network of industry contacts to help portfolio companies navigate challenges and scale effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.